Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Vet
Pets & Animals/Pet Medications

Elanco Animal: Galliprant (grapiprant) Tablets Recalled for Mismatched Packaging Strengths

Agency Publication Date: March 21, 2018
Share:
Sign in to monitor this recall

Summary

Elanco Animal is recalling approximately 61,219 bottles of Galliprant (grapiprant tablets), a medication used to treat pain and inflammation in dogs, because some bottles were placed in outer cartons that list the wrong dosage strength. Specifically, 20mg bottles may be in 60mg cartons, and 60mg bottles may be in either 20mg or 100mg cartons. This labeling error was discovered by the firm and could lead to pet owners or veterinarians administering the incorrect amount of medication to an animal. Owners should check the dosage strength printed on the actual bottle inside the box to ensure it matches their pet's prescription.

Risk

The mismatched labeling creates a risk that a dog will receive significantly more or less medication than prescribed. An incorrect dose could lead to ineffective treatment of pain or potential adverse side effects from an overdose.

What You Should Do

  1. Immediately check your Galliprant (grapiprant tablets) packaging to ensure the dosage strength (mg) and tablet count printed on the inner plastic bottle match the information on the outer cardboard carton.
  2. Check the lot numbers on your product labels. For 20mg (90-count) bottles, look for lot number 400179. For 60mg (30-count) bottles, look for lot numbers 400163, 400176, or 400185.
  3. If you find a discrepancy between the bottle and the carton, or if you have an affected lot number, do not administer any more medication from that package until you have confirmed the correct dose.
  4. Contact your veterinarian or pharmacist immediately to confirm that your pet has been receiving the correct dose and to discuss any health concerns.
  5. Return any affected or mismatched products to the pharmacy or veterinary clinic where they were purchased for a refund and to receive a correctly labeled replacement.
  6. Contact Elanco Animal or the distributor at 250 Innovation Way, Greenfield, Indiana, for further instructions on the recall process.
  7. For additional information, you can contact the FDA's Center for Veterinary Medicine at 240-402-7002.

Your Remedy Options

๐Ÿ’ฐFull Refund

Return mismatched products for a refund or replacement.

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Galliprant (grapiprant tablets), 20mg (90 tablets per bottle)
Model:
NDC: 86026-001-26
NADA: 141-455
Lot Numbers:
400179
Product: Galliprant (grapiprant tablets), 60mg (30 tablets per bottle)
Model:
NDC: 86026-002-23
NADA: 141-455
Lot Numbers:
400163
400176
400185

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 78555
Status: Resolved
Manufacturer: Elanco Animal
Sold By: veterinary clinics; animal hospitals; pharmacies
Manufactured In: United States
Units Affected: 2 products (11,174 bottles; 50,045 bottles)
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response